Structural and Functional Impact of Posttranslational Modification of Glypican-3 on Liver Carcinogenesis
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jan 2023 · 1 min read
In brief
In brief
This review examines how posttranslational modifications of glypican-3 (GPC3), including cleavage and glycosylation, influence its oncogenic role in hepatocellular carcinoma. The authors propose that dysregulated PTM of GPC3 drives liver carcinogenesis and epithelial-mesenchymal transition, offering insights for targeted drug development.
Written by the GCMD Library team from the article.
Statements in this article
Glypican-3 is a cell-surface glycoprotein that is frequently overexpressed in hepatocellular carcinoma.
Glypican-3 undergoes extensive posttranslational modification including cleavage and glycosylation.
The function of Glypican-3 in normal development can vary with extensive posttranslational modification.
Dysregulation of posttranslational modification processes of Glypican-3 leads to disease.
Defining the regulatory impact of posttranslational modifications can provide a deeper understanding of the role of Glypican-3 in oncogenesis, epithelial-mesenchymal transition, and drug development.